Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-025194

Chief Business Officer sold 6,944 shares at $51.40 ($356,956)

  • Chief Business Officer acquired 6,944 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parrish Jay · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-01 Exercise or conversion : show line 1 in the form +4,629 $1.49 $6,874 13,889 D
2021-04-01 Exercise or conversion : show line 2 in the form +2,315 $1.58 $3,646 16,204 D
2021-04-01 Sale : show line 3 in the form −6,944 $51.40 $356,956 9,260 D
Open-market sales · 6,944 sh · avg $51.40 · $356,956

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-04-01 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −4,629 4,630 D
2021-04-01 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −2,315 37,037 D
Loading xslF345X03/doc4.xml…